Lineage Newsroom

Morgan Stanley Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $95

Moomoo NewsDec 27 11:32 ET

Positive Outlook and Strategic Positioning Drive Buy Rating for Lineage, Inc.

TipRanksDec 27 10:36 ET

J.P. Morgan Downgrades Lineage(LINE.US) to Hold Rating, Cuts Target Price to $75

Moomoo NewsDec 20 13:43 ET

J.P. Morgan Downgrades Lineage, Inc. (LINE) to a Hold

TipRanksDec 20 13:20 ET

Lineage Price Target Cut to $75.00/Share From $78.00 by JP Morgan

Dow JonesDec 20 07:26 ET

Lineage Cut to Neutral From Overweight by JP Morgan

Dow JonesDec 20 07:26 ET

JP Morgan Downgrades Lineage to Neutral, Lowers Price Target to $75

BenzingaDec 20 07:17 ET

Lineage Analyst Ratings

BenzingaDec 20 07:16 ET

Truist Financial Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $80

Moomoo NewsDec 16 07:31 ET

Truist Financial Sticks to Their Buy Rating for Lineage, Inc. (LINE)

TipRanksDec 16 06:59 ET

Scotiabank Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $76

Moomoo NewsDec 10 10:31 ET

Lineage Is Maintained at Sector Outperform by Scotiabank

Dow JonesDec 10 08:32 ET

Evercore Maintains Lineage(LINE.US) With Hold Rating, Cuts Target Price to $73

Moomoo NewsDec 9 08:33 ET

Lineage, Inc. (LINE) Receives a Hold From Evercore ISI

TipRanksDec 9 08:14 ET

Lineage Cell Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesDec 4 06:26 ET

Lineage Cell Therapeutics Analyst Ratings

BenzingaDec 4 06:16 ET

J.P. Morgan Remains a Buy on Lineage, Inc. (LINE)

TipRanksNov 25 07:12 ET

Wells Fargo Maintains Lineage(LINE.US) With Hold Rating

Moomoo NewsNov 19 03:41 ET

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TipRanksNov 19 01:54 ET

D. Boral Capital Initiates Coverage On Lineage Cell Therapeutics With Buy Rating, Announces Price Target of $3

BenzingaNov 18 10:13 ET